What this study is
Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.
What's being tested
- Biopsy or surgery
Intervention · PROCEDURE
The tissue will be obtained from biopsy or surgical resection. All the "intervention" will be performed for clinical needs. The tissue used in the study will be considered as discarded tissue
Study details
- Sponsor
- University of Maryland, Baltimore
- Conditions
- Tracheal Stenosis · Subglottic Stenosis
- Enrolling
- 10 people
- Starts
- 2025-09-11
- Est. completion
- 2026-12-31
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients with benign tracheal stenosis
You can't join if
- Malignancy. active infection
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUniversity of Maryland
Baltimore, Maryland, United States
- Chenchen Zhang · Contact4103288141chenchen.zhang@som.umaryland.edu
Recruiting
Study team
Sponsor
University of Maryland, Baltimore
Study ID HP-00114191
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.